New York State Teachers Retirement System lifted its position in Docusign Inc. (NASDAQ:DOCU - Free Report) by 4.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 196,624 shares of the company's stock after acquiring an additional 9,236 shares during the period. New York State Teachers Retirement System owned 0.10% of Docusign worth $15,315,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DOCU. Banque Transatlantique SA acquired a new position in shares of Docusign in the first quarter valued at about $26,000. Hemington Wealth Management boosted its position in Docusign by 318.1% in the first quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after buying an additional 264 shares during the last quarter. Golden State Wealth Management LLC boosted its position in Docusign by 519.4% in the first quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after buying an additional 322 shares during the last quarter. Summit Securities Group LLC purchased a new position in Docusign during the 1st quarter worth approximately $34,000. Finally, Rise Advisors LLC lifted its stake in Docusign by 864.6% during the 1st quarter. Rise Advisors LLC now owns 463 shares of the company's stock valued at $38,000 after acquiring an additional 415 shares during the period. Hedge funds and other institutional investors own 77.64% of the company's stock.
Insider Buying and Selling
In other Docusign news, CFO Blake Jeffrey Grayson sold 6,500 shares of the company's stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $71.20, for a total transaction of $462,800.00. Following the completion of the transaction, the chief financial officer directly owned 105,660 shares in the company, valued at approximately $7,522,992. This represents a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider James P. Shaughnessy sold 7,500 shares of the stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $71.19, for a total transaction of $533,925.00. Following the transaction, the insider directly owned 55,442 shares in the company, valued at approximately $3,946,915.98. The trade was a 11.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 102,533 shares of company stock worth $7,709,933 in the last 90 days. 1.01% of the stock is owned by insiders.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on DOCU. Royal Bank Of Canada increased their price objective on shares of Docusign from $90.00 to $95.00 and gave the stock a "sector perform" rating in a research note on Friday, September 5th. Robert W. Baird upped their price target on shares of Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a report on Friday, September 5th. Wall Street Zen raised Docusign from a "hold" rating to a "buy" rating in a research report on Saturday, September 13th. Citigroup boosted their price objective on Docusign from $110.00 to $115.00 and gave the company a "buy" rating in a report on Thursday, September 4th. Finally, Zacks Research raised Docusign from a "hold" rating to a "strong-buy" rating in a report on Tuesday, September 9th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fifteen have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $94.14.
View Our Latest Stock Report on DOCU
Docusign Stock Up 1.2%
NASDAQ:DOCU opened at $67.93 on Friday. Docusign Inc. has a 52 week low of $66.35 and a 52 week high of $107.86. The stock's 50-day moving average price is $75.02 and its 200-day moving average price is $77.93. The stock has a market capitalization of $13.66 billion, a PE ratio of 51.08, a price-to-earnings-growth ratio of 3.38 and a beta of 1.02.
Docusign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The company had revenue of $800.64 million for the quarter, compared to the consensus estimate of $780.35 million. During the same quarter in the prior year, the business posted $0.97 earnings per share. Docusign's revenue for the quarter was up 8.8% on a year-over-year basis. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Sell-side analysts expect that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.
Docusign Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.